Eli Lilly (NYSE:LLY) has partnered with Collaborative Drug Discovery to make its AI drug discovery platform, Lilly TuneLab, ...
In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...
When Daniel Haders, Ph.D., was working in venture capital, he was on the hunt for an AI-driven drug discovery company that ...
GSK is redesigning pharmaceutical research around AI, from data infrastructure to autonomous scientific agents. Its platforms ...
Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is ...
At AACR 2026, industry leaders discussed how oncology R&D is moving beyond isolated technological advances towards integrated ...
Key market opportunities in AI training datasets include the rising use of synthetic data to address data scarcity and ...
Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...
In December, The Conversation hosted a webinar on AI's revolutionary role in drug discovery and development. Science and technology editor Eric Smalley interviewed Jeffrey Skolnick, eminent scholar in ...
In all the worthy discussions around the promise and peril of AI, we may be overlooking one of its most powerful use cases: solving urgent global health crises. Few problems illustrate this better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results